Here, to the best of our knowledge, for the first time, we illustrated the new mRNA modification types in a global epitranscriptomic map of CD4+ T cells from SLE patients versus HCs, uncovering multiple modifications in CD4+ T cells of SLE patients that are distinctly different from those in CD4+ T cells of HCs. This evidence concerns the gene CD4 and systemic lupus erythematosus.